These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
397 related items for PubMed ID: 16741553
21. Hepatorenal syndrome: new perspectives in pathophysiology and management. Kes P. Acta Med Croatica; 2000; 54(4-5):165-73. PubMed ID: 11379481 [Abstract] [Full Text] [Related]
22. Hepatorenal syndrome: a review. Testino G, Ferro C. Hepatogastroenterology; 2010; 57(102-103):1279-84. PubMed ID: 21410072 [Abstract] [Full Text] [Related]
23. TIPS or vasoconstrictors for the treatment of hepatorenal syndrome type 1--effect on survival? Gülberg V, Gerbes AL. Z Gastroenterol; 2002 Sep; 40(9):823-6. PubMed ID: 12215953 [Abstract] [Full Text] [Related]
24. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention? Møller S, Henriksen JH. Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398 [Abstract] [Full Text] [Related]
25. Review article: prognosis of hepatorenal syndrome--has it changed with current practice? Angeli P. Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():44-6; discussion 47-8. PubMed ID: 15335400 [Abstract] [Full Text] [Related]
26. Hepatorenal syndrome. Cárdenas A, Arroyo V. Ann Hepatol; 2003 Sep; 2(1):23-9. PubMed ID: 15094702 [Abstract] [Full Text] [Related]
27. The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond. Moreau R, Lebrec D. Hepatology; 2006 Mar; 43(3):385-94. PubMed ID: 16496352 [Abstract] [Full Text] [Related]
28. [Hepatorenal syndrome in patients with liver cirrhosis]. Zaza S, Bonny O, Liaudet L. Nephrol Ther; 2005 Jul; 1(3):174-82. PubMed ID: 16895684 [Abstract] [Full Text] [Related]
29. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome. Arroyo V, Terra C, Ginès P. J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801 [No Abstract] [Full Text] [Related]
30. Hepatorenal syndrome. Guevara M, Ginès P. Dig Dis; 2005 May; 23(1):47-55. PubMed ID: 15920325 [Abstract] [Full Text] [Related]
31. Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome. Møller S, Bendtsen F, Henriksen JH. Scand J Gastroenterol; 2005 May; 40(5):491-500. PubMed ID: 16036500 [Abstract] [Full Text] [Related]
32. [Therapy of hepatorenal syndrome]. Walter E. Praxis (Bern 1994); 1997 Jan 21; 86(4):102-3. PubMed ID: 9064719 [Abstract] [Full Text] [Related]
33. Pathophysiology, clinical features and management of hepatorenal syndrome. Garzia P, Ferri GM, Ilardi M, Messina FR, Amoroso A. Eur Rev Med Pharmacol Sci; 1998 Jan 21; 2(5-6):181-4. PubMed ID: 10710816 [Abstract] [Full Text] [Related]
35. [Hepatorenal syndrome]. Radziszewski A, Sułowicz W. Przegl Lek; 2006 Apr 21; 63(7):573-8. PubMed ID: 17203812 [Abstract] [Full Text] [Related]
36. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis. Gentilini P, Laffi G, La Villa G, Raggi VC. Ann Ital Med Int; 1999 Apr 21; 14(4):264-84. PubMed ID: 10638019 [Abstract] [Full Text] [Related]
37. [Diagnostics and therapy of hepatorenal syndrome. Recommendations of of the working group on portal hypertension of the Czech Hepatology Society and the J. E. Purkinje Czech Medical Society]. Brůha R, Skupiny C, Balihar K, Drastich P, Hůlek P, Lata J, Petrtýl J, Procházka V, Spicák J, Vanásek T, Volfová M, Zdenek P, Czech Hepatology Society, J E Purkinje Czech Medical Society. Vnitr Lek; 2006 Jun 21; 52(6):649-50. PubMed ID: 16871772 [Abstract] [Full Text] [Related]
38. [Hepatorenal syndrome]. Pŭrvanov P. Khirurgiia (Sofiia); 2002 Jun 21; 58(2):34-9. PubMed ID: 12515019 [Abstract] [Full Text] [Related]
39. [Hepatorenal syndrome: pathogenesis and treatment]. Ashkenazi E, Ilan Y, Shoval D. Harefuah; 2007 Jun 21; 146(6):475-9, 499. PubMed ID: 17760404 [Abstract] [Full Text] [Related]